A股異動丨龍蟒佰利(002601.SZ)領漲鈦白粉概念股 上調各型號鈦白粉的售價
格隆匯2月8日丨龍蟒佰利(002601.SZ)漲逾4%領漲鈦白粉概念股,報42.38元,安寧股份漲約2%。龍蟒佰利2月7日晚間公吿,自即日起,公司各型號鈦白粉銷售價格在原價基礎上對國內各類客户上調1000元人民幣/噸,對國際各類客户上調150美元/噸,個別型號根據實際情況調整。2020年上半年,受國內外新冠肺炎疫情蔓延影響,鈦白粉市場價格加速下滑。但此後,從2020年7月至今,該行業掀起了持續漲價浪潮,累計漲幅和漲價時長均為近年罕見。據悉,現階段主力生產商外貿出口接單狀況良好,目前部分已接單至3月中下旬,按照以往的出口供應優先情況來看,國內供應端現貨緊張局面或持續。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.